Clinical Trials Arena July 11, 2024
Investors continue to take a cautious approach while searching for novel candidates in an increasingly crowded oncology landscape.
As biotechs pull resources out of thinner budgets, investors are still being cautious with their investments compared to funding highs seen a few years ago.
Experts deliberated the regulatory and financial factors influencing the current state of oncology clinical trials at the 13th Annual Clinical Trials in Oncology East Coast 2024 conference, being held 9 – 10 July in Burlington, Massachusetts.
In the last few years, to combat increasing inflation, the government increased interest rates, which have held steady in the last few months. This environment in turn has made it difficult for venture capitalists to ensure above market returns, said Sally...
Today's Sponsors
Today's Sponsor